openPR Logo
Press release

Japan breast augmentation market 2025: Industry Developments, Future Growth, Share & Industry Insights | Establishment Labs Inc., AbbVie Inc., Sientra, Inc., Johnson & Johnson, and GC Aesthetics

11-10-2025 01:42 PM CET | Health & Medicine

Press release from: DataM Intelligence 4 Market Research LLP

Japan breast augmentation market - DataM Intelligence

Japan breast augmentation market - DataM Intelligence

The Japan breast augmentation market reached US$ 131.14 million in 2024 and is expected to reach US$ 227.43 million by 2033, growing at a CAGR of 7.10 % during the forecast period 2025-2033.

According to DataM Intelligence Comprehensive Report has released its latest report on the "Japan Breast Augmentation Market Size 2025," providing a detailed analysis of market trends, key growth drivers, competitive landscape, and regional insights. The report includes market size (value and volume), CAGR projections, and emerging opportunities that help businesses identify growth areas and build effective strategies. Backed by data-driven insights and future outlook, this study serves as a valuable resource for companies looking to stay competitive and capitalize on market potential.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://datamintelligence.com/download-sample/japan-breast-augmentation-market?sg

Industry Developments:

✅ 2025-05-28 - 2025-05-30 - Japan Society of Aesthetic Surgery (JSAS) 113th Congress held in Tokyo (major national meeting where breast-augmentation techniques, devices and clinical data were presented).

✅ 2025-07-22 - PMDA "Updates, Summer 2025" bulletin published (continued PMDA outreach/consultations and regulatory activity affecting medical devices and aesthetic-device consultations).

✅ 2025-07-17 - SBC Medical Group announced acquisition of MB Career Lounge ("JUN CLINIC"), signalling consolidation among Japan clinic operators that offer breast-augmentation services.

✅ 2025-03-06 - Establishment Labs publicized a global marketing/brand partnership (Meghan Trainor) while continuing Japan market activity (company has been active in Japan with earlier Mia Femtech rollouts).

✅ 2025-05-08 - GC Aesthetics announced strategic board appointments as part of growth plans (company active in breast-implant product promotion and clinical programmes).

✅ 2025-06-18 - 2025-06-21 - GC Aesthetics exhibited/participated at international aesthetic surgery congresses (ISAPS/Others) during 2025, promoting implant portfolio used in markets including Japan.

✅ 2025 - Publication: "Breast Augmentation in Body Contouring Using Autologous Stem Cell-Enriched Fat Grafting: Fifteen-Year Clinical Experience" (J. Clin. Med., 2025) - highlights ongoing clinical traction for fat-grafting alternatives/adjuncts to implants.

Get Customization in the report as per your requirements: https://datamintelligence.com/customize/japan-breast-augmentation-market?sg

Key Segments:

By Augmentation Type - Breast Implants, Fat Transfer Augmentation

By Application - Reconstructive Surgery, Cosmetic Surgery

By End-User - Hospitals, Cosmetology Clinics

Buy Now & Get 30% OFF - (Grab 50% OFF on 2+ reports) @ https://www.datamintelligence.com/buy-now-page?report=japan-breast-augmentation-market?sg

Key Market Drivers:

✅ Growing Aesthetic Consciousness:
A shift in beauty standards, influenced by social media and K-beauty trends, is driving more women in Japan to seek breast enhancement procedures for natural-looking results and body confidence.

✅ Technological Advancements in Implants:
The introduction of next-generation implants with improved safety, durability, and aesthetic appeal-such as cohesive silicone gel implants and anatomical designs-is fueling market demand.

✅ Rise in Minimally Invasive Procedures:
Non-surgical and hybrid procedures such as autologous fat transfer are gaining popularity, offering more natural outcomes and shorter recovery times compared to traditional methods.

✅ Increasing Medical Tourism:
Japan's reputation for quality healthcare and experienced cosmetic surgeons attracts regional patients, particularly from South Korea, China, and Southeast Asia, boosting the country's procedural volume.

✅ Supportive Regulatory Environment:
The Japanese government's focus on healthcare quality standards and device safety approvals ensures patient trust, encouraging adoption of FDA- and PMDA-approved implants.

Have any Query We Will Provide in Detailed @ https://www.datamintelligence.com/enquiry/japan-breast-augmentation-market?sg

Major Key Player: Establishment Labs Inc., AbbVie Inc., Sientra, Inc., Johnson & Johnson, and GC Aesthetics

Establishment Labs (Motiva) - Motiva implants received PMDA approval and the company has been actively launching Motiva products and clinic partnerships in Japan since 2022-2023, positioning Establishment Labs as a growing, innovation-led entrant with a formal commercial footprint in the Japanese market.

AbbVie (Allergan/Mentor historically) - AbbVie (via the former Allergan implant portfolio) is the global market leader in breast implants and is broadly recognized as the largest single supplier in many markets (reported ~23% global share in recent market analyses), making it a top incumbent in Japan as well.

Sientra - Sientra entered Japan via regulatory approval and an exclusive distribution partnership (Medical U&A) to sell its OPUS/OPUS portfolio to hospitals and clinics across Japan, giving it a clear, direct commercial presence though smaller share vs. the large incumbents.

Johnson & Johnson (MENTOR) - Mentor (J&J) is one of the largest global implant brands (frequently cited just behind the leading Allergan/AbbVie business) with long-standing product availability and surgeon adoption in Japan - a major established competitor in both augmentation and reconstruction segments.

GC Aesthetics (GCA) - GC Aesthetics is a growing international manufacturer/distributor (presence in 70+ countries) focused on product innovation (recent MDR-approved launches) and strategic partnerships - an expanding mid-tier supplier in APAC including activity directed at Japan via regional distributors.

Get 2-Day Free Trial + 50% OFF DataM Subscription@ https://www.datamintelligence.com/reports-subscription?sg

Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.

Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Japan breast augmentation market 2025: Industry Developments, Future Growth, Share & Industry Insights | Establishment Labs Inc., AbbVie Inc., Sientra, Inc., Johnson & Johnson, and GC Aesthetics here

News-ID: 4262035 • Views:

More Releases from DataM Intelligence 4 Market Research LLP

Healthcare Supply Chain Management Market Size USD 11.58 Billion by 2033, CAGR 14.9%, North America Leads the Market | Key Players SAP SE, Oracle Corporation, McKesson Corporation
Healthcare Supply Chain Management Market Size USD 11.58 Billion by 2033, CAGR 1 …
The Global Healthcare Supply Chain Management Market reached US$ 3.41 billion in 2024 and is expected to reach US$ 11.58 billion by 2033, growing at a CAGR of 14.9% during the forecast period 2025-2033. Market growth is driven by increasing demand for cost-efficient healthcare operations, rising complexity in medical supply networks, and the need for improved visibility and resilience across healthcare systems. Hospitals, pharmaceutical companies, and medical device manufacturers are
United States Oncolytic Viral Therapy Market to hit US$ 164.51 Million by 2033 | North America's Led by 45% Market Share | Top Companies - Coastar Theapeutics Inc., IconOVir Bio, Inc., and Calidi Biotherapeutics, Inc
United States Oncolytic Viral Therapy Market to hit US$ 164.51 Million by 2033 | …
Oncolytic Viral Therapy Market Size reached US$ 24.48 Million in 2024 and is expected to reach US$ 164.51 Million by 2033, growing at a CAGR of 23.8% during the forecast period 2025-2033. DataM Intelligence unveils its latest report on the "Oncolytic Viral Therapy Market Size 2025," offering an in-depth analysis of market trends, growth drivers, competitive landscape, and regional dynamics. The study covers market size in value and volume, CAGR forecasts,
Buy Now Pay Later Market is set to reach US$ 238.56 billion by 2033. Strong CAGR of 21.04%. North America leads with 45% market share | Key Players:- Affirm, Inc., Klarna Inc., Splitit USA Inc
Buy Now Pay Later Market is set to reach US$ 238.56 billion by 2033. Strong CAGR …
The global buy now pay later market reached US$ 35.47 billion in 2023, with a rise to US$ 42.78 billion in 2024, and is expected to reach US$ 238.56 billion by 2033, growing at a CAGR of 21.04% during the forecast period 2025-2033. The global buy now pay later market is witnessing robust growth, driven by rising consumer demand for flexible payment options, rapid digitalization of commerce, and increasing adoption
Biologics Contract Manufacturing Market Size USD 83.47 Billion by 2033, CAGR 14.0%, North America Leads the Market | Key Players Lonza, Samsung Biologics, Wuxi Biologics
Biologics Contract Manufacturing Market Size USD 83.47 Billion by 2033, CAGR 14. …
The global Biologics Contract Manufacturing Market reached US$ 26.03 billion in 2024 and is expected to reach US$ 83.47 billion by 2033, growing at a CAGR of 14.0% during the forecast period 2025-2033. Market growth is driven by rising demand for biologic drugs, increasing research and development investments by biopharmaceutical and biotech companies, and strategic collaborations with contract manufacturing organizations (CMOs) to scale production efficiently and reduce time-to-market. North America continues

All 5 Releases


More Releases for Japan

Vision Guided Robotic Systems Market Size 2022 - FANUC(Japan), KUKA(Germany), AB …
The Vision Guided Robotic Systems Market research report also provides an in-depth analysis of key players in the market, including their company profiles, business offerings, recent development, market strategies, and critical observation related to the product. The research study provides extensive coverage of the Vision Guided Robotic Systems Market size across all industries and businesses. In addition, it offers detailed insights into market size and growth depending upon various segments
Japan Agriculture Market, Japan Agriculture Industry, Japan Agriculture Livestoc …
The agriculture sector is a very significant sector in Japan. Agriculture sector exists in every part of country, but is especially essential on the northern island of Hokkaido that accounts for approximately 10% of national production. Modern methods such as commercial fertilizers, hybrid seeds, insecticides, and machinery, have been used so efficiently in farming. Japan is the second major agricultural product importer in the world (after the U.S.). Almost all
Car Navigation ECU Market 2019: Top Key Players are AW Software (Japan), Contine …
Car Navigation ECU Market 2019 Report analyses the industry status, size, share, trends, growth opportunity, competition landscape and forecast to 2025. This report also provides data on patterns, improvements, target business sectors, limits and advancements. Furthermore, this research report categorizes the market by companies, region, type and end-use industry. Get Sample Copy of this Report@ https://www.researchreportsworld.com/enquiry/request-sample/13844912 Global Car Navigation ECU market 2019 research provides a basic overview of the industry
Global Car Navigation ECU Market Outlook to 2023 – AW Software (Japan), Contin …
An automotive navigation system is part of the automobile controls or a third party add-on used to find direction in an automobile and the ECU is the core part control it. Car Navigation typically uses a satellite navigation device to get its position data which is then correlated to a position on a road. According to this study, over the next five years the Car Navigation ECU market will register a
Global Car Navigation Parts Market Research Report 2019-2025  | Global Key Play …
This research report titled “Global Car Navigation Parts Market” Insights, Forecast to 2025 has been added to the wide online database managed by Market Research Hub (MRH). The study discusses the prime market growth factors along with future projections expected to impact the Car Navigation Parts Market during the period between 2018 and 2025. The concerned sector is analyzed based on different market factors including drivers, restraints and opportunities in
Global Automotive 3D Scanning Laser Radar (3D-LiDAR) Market 2019-2025 | Velodyne …
Researchmoz added Most up-to-date research on "Global Automotive 3D Scanning Laser Radar (3D-LiDAR) Market Insights,Forecast to 2025" to its huge collection of research reports. 3D LiDAR uses a pulsed laser to detect distance, velocity and angle with high precision. LiDAR can classify objects, detect lane markings, and may also be used to accurately position an autonomous vehicle relative to a high definition map. 3D LiDAR is prominent, as it is a key